33 studies found for:    " September 22, 2010":" October 22, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Active, not recruiting
Has Results
A Study of GSK1349572 Versus Raltegravir (RAL) With Investigator Selected Background Regimen in Antiretroviral-Experienced, Integrase Inhibitor-Naive Adults
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: GSK1349572;   Drug: Raltegravir;   Drug: GSK1349572 Placebo;   Drug: Raltegravir Placebo
22 Completed GSK1349572 Hepatic Impairment Study
Conditions: Healthy Subjects;   Hepatic Impairment;   Infection, Human Immunodeficiency Virus
Intervention: Drug: GSK1349572
23 Completed A Phase 1, Open Label, Placebo-Controlled Study to Evaluate the Effect of GSK1349572 on Iohexol and Para-Aminohippurate Clearance in Healthy Subjects
Condition: Infections, Human Immunodeficiency Virus and Tuberculosis
Interventions: Drug: GSK1349572;   Drug: Placebo;   Drug: Iohexol Injection;   Drug: Para-aminohippurate infusion
24 Recruiting Multiplex Microarray Chip-Based Diagnosis of Respiratory Infections
Condition: HIV
Intervention:
25 Completed Young Women's CoOp Study
Conditions: HIV;   Sexual Risk;   Sexually Transmitted Diseases;   Substance Abuse;   Violence;   Victimization
Interventions: Behavioral: Young Women's CoOp;   Behavioral: Staying Healthy and Eating Well
26 Recruiting Reducing Heavy Drinking to Optimize HIV/AIDS Treatment and Prevention
Condition: Reduction in Heavy Drinking in Patients With HIV
Interventions: Drug: Naltrexone;   Other: Placebo + Medication Management/Medication Coaching
27 Unknown  Safety Study of Raltegravir in HIV/HCV Co-infected Patients
Conditions: HIV;   Hepatitis C
Interventions: Drug: raltegravir;   Drug: Atazanavir/ritonavir
28 Completed Efficacy and Safety of GSK Biologicals HIV Vaccine in Antiretroviral Therapy (ART)-naïve HIV-1 Infected Persons
Condition: AIDS
Interventions: Biological: GSK Biologicals HIV Vaccine 732462;   Drug: Placebo
29 Completed Estimate The Effect Of Lersivirine On The Pharmacokinetics Of Abacavir/Lamivudine In Healthy Subjects
Condition: Healthy Volunteers
Interventions: Drug: Abacavir/Lamivudine;   Drug: Lersivirine
30 Unknown  EMBRACE (Evaluation of Maternal and Baby Outcome Registry After Chemoprophylactic Exposure)
Condition: Pregnancy Outcome
Intervention:
31 Completed Safety And Tolerability Of Multiple Dose Lersivirine For 21 Days In Healthy Subjects
Condition: Healthy Volunteers
Intervention: Drug: Lersivirine
32 Active, not recruiting Third Line Highly Active Antiretroviral Therapy (HAART) in HIV-infected Children
Condition: This Study is Designed to Collect Treatment Data of Thai Children on Third Line ARV Therapy.
Intervention:
33 Completed Family Planning Through Dairy Cooperatives
Conditions: The Study Goal is to Assess the Introduction of Sustainable Family Planning/Reproductive Health Information and Services Through;   Land O' Lakes-supported Dairy Cooperatives
Intervention:

Show previous page of results Previous Page (1-20) Studies Shown (21-33) Next Page
Indicates status has not been verified in more than two years